Development of a specific activin antagonist for therapeutic applications

Project: Research

Status	Finished
Effective start/end date	1/01/11 → 31/03/14

Aberrant GDF9 expression and activation are associated with common human ovarian disorders
Simpson, C. M., Robertson, D. M., Al-Musawi, S. L., Heath, D., McNatty, K., Ritter, L. J., Mottershead, D. G., Gilchrist, R., Harrison, C. A. & Stanton, P. G., 2014, In: The Journal of Clinical Endocrinology & Metabolism. 99, 4, p. 615 - 624 10 p.
Research output: Contribution to journal › Article › Research › peer-review

31 Citations (Scopus)
Elevated expression of activins promotes muscle wasting and cachexia
Chen, J. L., Walton, K., Winbanks, C. E., Murphy, K. T., Thomson, R. E., Makanji, Y., Qian, H., Lynch, G. S., Harrison, C. A. & Gregorevic, P., 2014, In: The FASEB Journal. 28, 4, p. 1711 - 1723 13 p.
Research output: Contribution to journal › Article › Research › peer-review

170 Citations (Scopus)
Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin
Winbanks, C. E., Weeks, K. L., Thomson, R. E., Sepulveda, P. V., Beyer, C., Qian, H., Chen, J. L., Allen, J. M., Lancaster, G. I., Febbraio, M. A., Harrison, C. A., McMullen, J. R., Chamberlain, J. S. & Gregorevic, P., 28 Jun 2012, In: Journal of Cell Biology. 197, 7, p. 997-1008 12 p.
Research output: Contribution to journal › Article › Research › peer-review

187 Citations (Scopus)

Project Details